News
PFE
27.84
+0.22%
0.06
5 Stocks Yielding 5% To Beat The Looming Retirement Crisis
Retirement crisis is looming as many people are unprepared for retirement and worry about inflation's impact on savings. BlackRock CEO Larry Fink suggests policymakers improve retirement systems and invest in energy infrastructure to address the crisis. Investing in undervalued stocks with solid balance sheets and dividend growth can offer a pathway to building a resilient retirement portfolio. Vladislav Stepanov discusses 5 stocks investors may consider for investment.
Seeking Alpha · 3h ago
Moderna (MRNA) Posts Upbeat Data From Next-Gen COVID Jab Study
NASDAQ · 22h ago
Giverny Capital Rochon Global Portfolio 2023 Annual Letter To Partners
Giverny Capital Rochon Global Portfolio 2023 Annual Letter To Partners. Giverny is a Montreal-based investment advisor specializing in private wealth management. The company has managed a family portfolio since 1993. Since its inception in 1993, the GivernY portfolio has had a compounded annual return of 14.8%.
Seeking Alpha · 23h ago
Is Most-Watched Stock Pfizer Inc. (PFE) Worth Betting on Now?
NASDAQ · 1d ago
3 No-Brainer Healthcare Stocks to Buy Right Now for Less Than $1,000
Three no-brainer healthcare buys can add diversification, safety, and growth to your portfolio. Pfizer is completing its biggest streak of product launches in 18 months. CRISPR Therapeutics recently won the world's first regulatory approval for a gene-editing product. Medtronic is a medical device giant that could be heading for a new era of growth.
The Motley Fool · 1d ago
U.S. Wide-Moat Stocks On Sale - The March 2024 Heat Map
Home Stock Ideas Quick Picks & Lists U.S. Wide-Moat Stocks On Sale - The March 2024 Heat Map. Our 3-step process focuses on wide-moat stocks with 5-star and 4-star ratings. Morningstar's moat rating is a good indicator of market sentiment. We share the heat map of the most investable candidates for further analysis.
Seeking Alpha · 1d ago
Adobe Revolutionizes Content Supply Chain With New Generative AI Tools
Adobe unveils suite of generative AI tools to transform the content supply chain. GenStudio and Firefly are designed to streamline the creation, management and deployment of marketing content. The initiative was unveiled at the Adobe Summit, a Digital Experience Conference. Adobe's initiative has garnered support from leading brands and agencies.
Benzinga · 1d ago
After Hours Most Active for Mar 26, 2024 : NIO, AUR, AAPL, HPE, GLW, PFE, AMZN, KO, INTC, GME, QQQ, GRAB
NASDAQ · 1d ago
Adobe unveils experimental AI journeys at Las Vegas summit
Adobe unveils experimental AI journeys at Las Vegas summit. Adobe and Microsoft announce a partnership to combine Adobe Experience Cloud with Microsoft Copilot and Microsoft 365. The company also announced a slate of innovations to its AI tool, Firefly, at the Adobe Summit in Las Vegas on Tuesday.
Seeking Alpha · 1d ago
Zoetis comes under EU antitrust probe over dog pain drug
U.S. Animal health company Zoetis comes under EU antitrust probe over dog pain drug. European Commission to probe whether company terminated rival to its dog pain therapy Librela. If charges are proven, Pfizer spinoff could be liable for a penalty of 10% of turnover.
Seeking Alpha · 1d ago
'Supreme Court Unlikely To Limit Access To Abortion Pill' - Washington Post
The Supreme Court seemed unlikely to limit access to mifepristone, a key medication used in more than 60 percent of U.S. Abortions. A majority of justices expressed skepticism that the antiabortion doctors have standing to sue. The government and the drug company say the drug is overwhelmingly safe.
Benzinga · 1d ago
SEC Explores New Territory in Insider Trading Case Against Ex-Biotech Exec
The U.S. Securities and Exchange Commission is testing the boundaries of insider trading laws. The SEC is suing a former biotech executive Matthew Panuwat for insider trading. The case hinges on whether he exploited confidential information about a potential takeover of his own company for personal gain. This case could redefine the legal definition of 'insider trading'
Barchart · 2d ago
Viking Therapeutics gains on early data for oral weight loss therapy
Seeking Alpha · 2d ago
UPDATE 1-China to speed up 'new productive forces', vice president says
China to bolster stability and security for global economy, vice president says at investment summit. Foreign businesses have been trying to reassure anxious foreign firms. China to speed up development of " productive forces" to attract foreign investment. The term "productive forces" was coined by President Xi Jinping last September.
Reuters · 2d ago
2 High-Yield Dividend Stocks You Can Buy With $100 Now and Hold Forever
Two stocks offer huge dividend yields of 9.1% and 6.1%. Altria Group and Pfizer offer investors a combined yield of more than 10%. The tobacco giant and the pharmaceutical giant have raised their dividends for the past 58 years. The two companies offer huge potential to grow their dividends in the future.
The Motley Fool · 2d ago
Pfizer (PFE) Gains As Market Dips: What You Should Know
NASDAQ · 2d ago
4 Fortune 500 Industry Leaders Boast Ideal March Dividends
Fortune magazine's 2023 list of 500 biggest U.S. Companies by revenue includes 68 industry leaders. Four of the top ten F500-IL dividend stocks by yield are among the ideal best to buy in March 2024. Energy Transfer LP (ET), Verizon Communications (VZ), Pfizer (F) and Ford Motor are the top four of 58 for the Fortune 500 industry leader list. Top ten of 58 by yield for the F500 500 industry leaders are projected to make 11.35% to 24.71% net gains.
Seeking Alpha · 2d ago
German industry sceptical of China's vow to treat foreign firms equally
German industry sceptical of China's vow to treat foreign firms equally China pledges equal treatment for foreign firms German VDMA: announcement part of 'friendly signs' offensive Move aimed at keeping foreign firms engaged in China. German direct investment in China rose to a record high of 11.9 billion euros last year.
Reuters · 3d ago
UPDATE 1-BioNTech gets notice from US agency over default on COVID vaccine royalties
BioNTech says U.S. National Institutes of Health has sent a to the German company over default in the payment of royalties. The dispute relates to its COVID-19 vaccine for which it partnered with Pfizer. The company says it intends to defend against all allegations of breach.
Reuters · 3d ago
Novo Nordisk and Eli Lilly May Finally Have Some Real Competition
Viking Therapeutics is a small biotech company looking to develop treatments for weight-loss disorders. The company recently announced positive indications from a phase 2 clinical trial for its obesity drug. Pfizer may be a suitable candidate to buy out Viking, but the company is speculative right now.
The Motley Fool · 3d ago
More
Webull provides a variety of real-time PFE stock news. You can receive the latest news about Pfizer through multiple platforms. This information may help you make smarter investment decisions.
About PFE
Pfizer Inc. is a research-based biopharmaceutical company. The Company is engaged in the discovery, development, manufacture, marketing, sale and distribution of biopharmaceutical products around the world. The Company operates through two segments: Biopharma and PC1. Biopharma is engaged in the science-based biopharmaceutical business. PC1 is its global contract development and manufacturing organization and supplier of specialty active pharmaceutical ingredients. The Company’s primary care products include Eliquis, Nurtec ODT/Vydura and the Premarin family; the Prevnar family, Nimenrix, FSME/IMMUN-TicoVac and Trumenba; Comirnaty, and Paxlovid. Its specialty care products include Xeljanz, Enbrel (outside the United States and Canada), Inflectra, Eucrisa/Staquis and Cibinqo; the Vyndaqel family, Oxbryta, BeneFIX and Genotropin, and Sulperazon, Medrol, Zavicefta, Zithromax, Vfend and Panzyga. Its oncology products include Ibrance, Xtandi, Inlyta, Retacrit, Lorbrena and Braftovi.